Total anomalous pulmonary venous connection medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Template:Total anomalous pulmonary venous connection}} | {{Template:Total anomalous pulmonary venous connection}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@elon.edu]] | ||
==Overview== | |||
Medical therapy are primarily used to stabilize the patient of total anomalous pulmonary venous connection. | |||
== | |||
Medical therapy are primarily used to stabilize the patient of total anomalous pulmonary venous connection | |||
==Medical Therapy== | |||
Prior to surgery the patients have to be stabilized. It may be achieved by: | |||
* Giving respiratory support by supplemental oxygen, [[mechanical ventilation]], [[extracorporeal membrane oxygenation]] (ECMO).<ref name="pmid6235060">{{cite journal| author=Lock JE, Bass JL, Castaneda-Zuniga W, Fuhrman BP, Rashkind WJ, Lucas RV| title=Dilation angioplasty of congenital or operative narrowings of venous channels. | journal=Circulation | year= 1984 | volume= 70 | issue= 3 | pages= 457-64 | pmid=6235060 | doi= | pmc= | url= }} </ref> | |||
* Inotropic support in progressive [[heart failure]]. | |||
* High ceiling [[diuretic]]s like [[furosemide]] for [[pulmonary edema]]. | |||
* [[Prostaglandin]] therapy to keep the ductus patent. | |||
* Palliative [[angiography]] can be used to create atrial septostomy in severely obstructed total anomalous pulmonary venous connection. | |||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Cardiovascular system]] | [[Category:Cardiovascular system]] | ||
| Line 28: | Line 21: | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 02:47, 9 April 2013
|
Total anomalous pulmonary venous connection Microchapters |
|
Differentiating Total anomalous pulmonary venous connection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Total anomalous pulmonary venous connection medical therapy On the Web |
|
American Roentgen Ray Society Images of Total anomalous pulmonary venous connection medical therapy |
|
FDA on Total anomalous pulmonary venous connection medical therapy |
|
CDC on Total anomalous pulmonary venous connection medical therapy |
|
Total anomalous pulmonary venous connection medical therapy in the news |
|
Blogs on Total anomalous pulmonary venous connection medical therapy |
|
Risk calculators and risk factors for Total anomalous pulmonary venous connection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3]; Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]
Overview
Medical therapy are primarily used to stabilize the patient of total anomalous pulmonary venous connection.
Medical Therapy
Prior to surgery the patients have to be stabilized. It may be achieved by:
- Giving respiratory support by supplemental oxygen, mechanical ventilation, extracorporeal membrane oxygenation (ECMO).[1]
- Inotropic support in progressive heart failure.
- High ceiling diuretics like furosemide for pulmonary edema.
- Prostaglandin therapy to keep the ductus patent.
- Palliative angiography can be used to create atrial septostomy in severely obstructed total anomalous pulmonary venous connection.